RSV Glycoprotein G (Protein | Antibody | cDNA Clone | ELISA Kit)

All RSV Glycoprotein G reagents are produced in house and quality controlled, including 4 RSV Glycoprotein G Antibody, 36 RSV Glycoprotein G Gene, 2 RSV Glycoprotein G IP Kit, 4 RSV Glycoprotein G Lysate, 4 RSV Glycoprotein G Protein. All RSV Glycoprotein G reagents are ready to use.

More Product Popular With Customers

RSV Glycoprotein G Related Research Area

RSV Glycoprotein G Background

Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. It is classified within the genus pneumovirus of the family paramyxoviridae. Like other members of the family, HRSV has two major surface glycoproteins (G and F) that play important roles in the initial stages of the infectious cycle. HRSV G protein is a type II glycoprotein of 289-299 amino acids (depending on the virus strain) with a signal/anchor hydrophobic domain and is extensively modified by the addition of both N-and O-linked oligosaccharides to achieve the mature form of 8-9 kDa. The C-terminal ectodomain of the G protein has a central region and four cysteines which are conserved in all HRSV isolates and have been proposed as the putative receptor binding site. The G protein mediates attachment of the virus to the host cell membrane by interacting with heparan sulfate, initiating the infection. As similar to mucins in amino acid compositions, the RSV G protein can interact with host CX3CR1, the receptor for the CX3C chemokine fractalkine, and thus modulates the immune response and facilitate infection. Secreted glycoprotein G helps RSV escape antibody-dependent restriction of replication by acting as an antigen decoy and by modulating the activity of leukocytes bearing Fcgamma receptors. Unlike the other paramyxovirus attachment proteins, HRSV-G lacks both neuraminidase and hemagglutinating activities.

RSV Glycoprotein G References

  • Martin-Gallardo A. et al., 1993, J Gen Virol. 74 : 453-8.
  • Jose AM. et al.,1997, J Gen Virol. 78: 2411-8.
  • Feldman SA. et al., 1999, J Virol. 73: 6610-7.
  • García-Beato R. et al., 2000, J Gen Virol. 81: 919-27.
  • Zlateva KT. et al., 2004, J Virol. 78: 4675-83.
  • Trento A. et al., 2006, J Virol. 80: 975-84.
彩票大奖得主捐赠 河南11选五开奖结果走势图 福建快3下载 山东11选5前三组选走势图 北京pk拾是骗局吗 江苏快3技巧稳赚方法 188金宝博娱乐城真钱百家乐 南风化工重组最新消息 股票涨跌免费预测 体彩贵州11选5开奖结果 大盘股一定是权重股